After several months of steadily climbing upwards, the stock market has taken a downturn lately. This recent pullback might provide buying opportunities for stocks that are in a good position to succeed both during and after the coronavirus pandemic. The two companies that I'm keeping an eye...
The stock is bouncing back today amidbetter news from the Biden administration, but ASML is stilldown about 22%from its recent highs. www.barchart.com Analysts maintain a consensus rating of “Strong Buy” on ASML stock, with amean target price of $1,154.75. This indicates expected upside ...
One way to tell if the public is overreacting negatively on a stock is to see if higher-ups at the company are buying – a move that must be publicly disclosed and is available on free sites such as Nasdaq and Yahoo Finance. “The number one thing we start with is insider buying...
as certain banks have restricted secondary trading of cannabis-related stocks that do not trade on either the New York Stock Exchange or NASDAQ. We believe that this has created a less than optimal trading volume and
and i compare where nvda stock stands today compared to previous down cycles. i also share the two price points i would be willing to buy nvidia stock should the price fall that far. and i take readers through my process for arriving at these buy prices. looking for a helping hand in ...
aggregators . governed by nerdwallet's strict guidelines for editorial integrity . nerdwallet's auto loans content, including articles, reviews and recommendations, is produced by a team of writers and editors who specialize in consumer lending. their work has appeared in nasdaq, msn, marketwatch,...
Despite a legacy of losses and trouble with the Nasdaq, CEO Ira Lampert has, since early December, spent roughly $46,000 to boost his position in the stock. What gives? Three things, from what I see. First, on Dec. 6, Concord announced it had met the market's minimum listing ...
Today, the CEO & President of Fastenal Company (NASDAQ:FAST),Daniel Florness, bought shares of FAST for $103.9K. Following Daniel Florness’ last FAST Buy transaction on December 06, 2012, the stock climbed by 15.9%. This recent transaction increases Daniel Florness’ holding in the company...
Today, a Director at Alexion Pharmaceuticals (NASDAQ: ALXN), Christopher J. Coughlin, bought shares of ALXN for $1.21M. This recent transaction increases
Bear in mind, the NASDAQ continued to fall into October 2002, handing even deeper losses to investors who continued to buy on the way down. Returning to 2020, only time will tell when the bear market has bottomed, if it hasn’t already done so. ...